Schedule 13G ownership disclosure

Atossa Therapeutics Inc

Security class unavailable · CUSIP: 04962H506

Event date: 2018-04-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-18-005062
Form type
SC 13G
Filer
ATOSSA THERAPEUTICS, INC.
CIK
CIK 1488039
Filed
Apr 27, 2018
Reporting period
Apr 23, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub